Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas

Research output: Contribution to journalArticle

Abstract

Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration. Copyright

Original languageEnglish (US)
Pages (from-to)423-429
Number of pages7
JournalCancer Investigation
Volume32
Issue number8
DOIs
StatePublished - Sep 14 2014

Fingerprint

Glioma
Blood Proteins
Biomarkers
Neurogranin
beta-Synuclein
Gliosarcoma
Proteins
Phosphopyruvate Hydratase
Glial Fibrillary Acidic Protein
Brain-Derived Neurotrophic Factor
Glioblastoma
Healthy Volunteers
Brain
growth inhibitory factor

Keywords

  • Brain Tumors
  • Cancer Biomarkers
  • Circulating Biomarkers
  • Glioma
  • Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas. / Lange, Ryan P.; Everett, Allen D; Dulloor, Pratima; Korley, Frederick; Bettegowda, Chetan; Blair, Cherie; Grossman, Stuart A; Holdhoff, Matthias.

In: Cancer Investigation, Vol. 32, No. 8, 14.09.2014, p. 423-429.

Research output: Contribution to journalArticle

@article{45996142e26c45479b415d38603f6da2,
title = "Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas",
abstract = "Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration. Copyright",
keywords = "Brain Tumors, Cancer Biomarkers, Circulating Biomarkers, Glioma, Proteins",
author = "Lange, {Ryan P.} and Everett, {Allen D} and Pratima Dulloor and Frederick Korley and Chetan Bettegowda and Cherie Blair and Grossman, {Stuart A} and Matthias Holdhoff",
year = "2014",
month = "9",
day = "14",
doi = "10.3109/07357907.2014.933237",
language = "English (US)",
volume = "32",
pages = "423--429",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas

AU - Lange, Ryan P.

AU - Everett, Allen D

AU - Dulloor, Pratima

AU - Korley, Frederick

AU - Bettegowda, Chetan

AU - Blair, Cherie

AU - Grossman, Stuart A

AU - Holdhoff, Matthias

PY - 2014/9/14

Y1 - 2014/9/14

N2 - Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration. Copyright

AB - Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration. Copyright

KW - Brain Tumors

KW - Cancer Biomarkers

KW - Circulating Biomarkers

KW - Glioma

KW - Proteins

UR - http://www.scopus.com/inward/record.url?scp=84907062215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907062215&partnerID=8YFLogxK

U2 - 10.3109/07357907.2014.933237

DO - 10.3109/07357907.2014.933237

M3 - Article

VL - 32

SP - 423

EP - 429

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 8

ER -